Delhi HC rejects Roche's plea to block Natco Pharma on Risdiplam patent
The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...
Pharmabiz4h
Relatives of rare disease requests CJI to help them access life-saving medicines at affordable cost
Our Bureau, New Delhi Thursday, April 3, 2025, 08:00 Hrs [IST] ...
Delhi HC tells Natco Pharma to pause launch of generic version of Risdiplam
Roche had appealed against a single judge order of March 24 that had refused to stop Natco Pharma from manufacturing a generic version of Risdiplam ...
Medical Dialogues9d
Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC
In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by ...
The Week8d
How Delhi High Court's latest verdict is a boon for spinal muscular atrophy patients
A rare genetic condition, Spinal Muscular Atrophy (SMA) affects one in 7,000 people in India. It mostly affects children and ...
Delhi HC denies interim injunction on Roche rare disease drug, opening the door for generic versions
Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug ...
HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest
The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.
Delhi HC restrains Natco Pharma from launching generic of Roche's rare disease drug
"Roche has filed an appeal against the Hon. Delhi High Court order and the matter is subjudice in the appeal court," Roche ...
Delhi HC denies stay against Natco Pharma, potentially paving way for affordable generic drug
The high court decision potentially opens the door for access to a generic version of the patented drug - Risdiplam - at a fraction of the cost marketed by the Swiss pharmaceutical major.
The Pharma Letter2d
Chugai gains Japan approval for Evrysdi as first tablet for SMA
Japanese drugmaker Chugai (TYO: 4519) has obtained regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) ...
Pharmabiz7d
Delhi HC rejects interim injunction plea from Roche against Natco's SMA drug Evrysdi
Delhi HC rejects interim injunction plea from Roche against Natco's SMA drug Evrysdi: Our Bureau, New Delhi Thursday, March 27, 2025, 08:00 Hrs [IST] The Delhi High Court has reje ...